Cargando…

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants

In recent years, DNA vaccines have undergone a number of technological advancements that have incited renewed interest and heightened promise in the field. Two such improvements are the use of genetically engineered cytokine adjuvants and plasmid delivery via in vivo electroporation (EP), the latter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flingai, Seleeke, Czerwonko, Matias, Goodman, Jonathan, Kudchodkar, Sagar B., Muthumani, Kar, Weiner, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816528/ https://www.ncbi.nlm.nih.gov/pubmed/24204366 http://dx.doi.org/10.3389/fimmu.2013.00354

Ejemplares similares

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo
por: Muthumani, Kar, et al.
Publicado: (2013)

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
por: Flingai, Seleeke, et al.
Publicado: (2015)

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
por: Xu, Ziyang, et al.
Publicado: (2020)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
por: Cuzzubbo, Stefania, et al.
Publicado: (2021)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

P16-36. Functional genomic immune profile of SIV DNA vaccines delivered by electroporation and combined with molecular adjuvants
por: Boyer, JD, et al.
Publicado: (2009)

Electroporation-Mediated DNA Vaccination
por: Fagone, Paolo, et al.
Publicado: (2010)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model
por: Louis, Lumena, et al.
Publicado: (2019)

Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation
por: Liang, Yan, et al.
Publicado: (2022)

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
por: Maslow, Joel N., et al.
Publicado: (2023)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
por: Cu, Yen, et al.
Publicado: (2013)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

The Safety and Immunogenicity of GTU(®)MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART
por: Haidari, G., et al.
Publicado: (2019)

Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation
por: Xie, Peng, et al.
Publicado: (2020)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants
por: Fuentes, Roberto, et al.
Publicado: (2022)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens
por: Sardesai, NY, et al.
Publicado: (2012)

Vaccine Adjuvants: Mode of Action
por: De Gregorio, Ennio, et al.
Publicado: (2013)

Chemokine Adjuvanted Electroporated-DNA Vaccine Induces Substantial Protection from Simian Immunodeficiency Virus Vaginal Challenge
por: Kutzler, M A, et al.
Publicado: (2015)

Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses
por: Jiang, Jingjing, et al.
Publicado: (2021)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)

Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
por: Sui, Yongjun, et al.
Publicado: (2023)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
por: Elliott, Sarah T. C., et al.
Publicado: (2017)

Vaccine Adjuvant Informatics: From Data Integration and Analysis to Rational Vaccine Adjuvant Design
por: He, Yongqun
Publicado: (2014)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device
por: Kim, Woo Joo, et al.
Publicado: (2023)

SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine
por: Qian, Jie, et al.
Publicado: (2023)

Adjuvants for Leishmania vaccines: from models to clinical application
por: Raman, Vanitha S., et al.
Publicado: (2012)

Cancer Vaccines, Adjuvants, and Delivery Systems
por: Paston, Samantha J., et al.
Publicado: (2021)

A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
por: Cashman, Kathleen A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sjnpsebh6fq1gov9dul25frcvm